1. Home
  2. Labeler Index
  3. Novel Laboratories, Inc.
  4. 40032-038
  5. NDC Package Code: 40032-038-60 Voriconazole

NDC Package 40032-038-60 Voriconazole

Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
40032-038-60
Package Description:
1 BOTTLE in 1 CARTON / 75 mL in 1 BOTTLE (40032-038-00)
Product Code:
40032-038
Proprietary Name:
Voriconazole
Non-Proprietary Name:
Voriconazole
Substance Name:
Voriconazole
Usage Information:
Voriconazole is used to treat a variety of fungal infections. It belongs to a class of drugs known as azole antifungals. It works by stopping the growth of fungi.
11-Digit NDC Billing Format:
40032003860
NDC to RxNorm Crosswalk:
  • RxCUI: 465355 - voriconazole 40 MG in 1 mL Oral Suspension
  • RxCUI: 465355 - voriconazole 40 MG/ML Oral Suspension
  • RxCUI: 465355 - voriconazole 200 MG/5 ML Oral Suspension
  • RxCUI: 465355 - voriconazole 40 MG per 1 ML Oral Suspension
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Novel Laboratories, Inc.
    Dosage Form:
    Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
    Administration Route(s):
  • Oral - Administration to or by way of the mouth.
    • Active Ingredient(s):
  • VORICONAZOLE 40 mg/mL
    • Pharmacologic Class(es):
  • Azole Antifungal - [EPC] (Established Pharmacologic Class)
  • Azoles - [CS]
  • Cytochrome P450 2C19 Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 2C9 Inhibitors - [MoA] (Mechanism of Action)
  • Cytochrome P450 3A4 Inhibitors - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    ANDA206799
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    06-01-2016
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 40032-038-60?

    The NDC Packaged Code 40032-038-60 is assigned to a package of 1 bottle in 1 carton / 75 ml in 1 bottle (40032-038-00) of Voriconazole, a human prescription drug labeled by Novel Laboratories, Inc.. The product's dosage form is suspension and is administered via oral form.

    Is NDC 40032-038 included in the NDC Directory?

    Yes, Voriconazole with product code 40032-038 is active and included in the NDC Directory. The product was first marketed by Novel Laboratories, Inc. on June 01, 2016 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 40032-038-60?

    The 11-digit format is 40032003860. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-240032-038-605-4-240032-0038-60